Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Metabolic modelling for drug development in Neisseria gonorrhoeae

FY 2020-21

Summary
Neisseria gonorrhoeae is the bacteria that causes the sexually transmitted infection gonorrhea. Antimicrobial resistant (AMR) N. gonorrhoeae strains have become more common, leading to concerns about the rise of untreatable gonorrhea infections. There is, therefore, an urgent need for the development of new therapies to treat gonococcal infections. This project seeks to identify and characterize new targets for drug development by combing powerful computational models with state-of-the-art laboratory techniques. First, a computational model of N. gonorrhoeae metabolism will be developed using publicly available sequence data from over 7400 global gonococcal isolates. Representative strains will be grown in a variety of infection-mimicking culture conditions, and their growth characteristics will be used to validate and improve our computational model. The model will then be used to identify essential pathways through large scale simulations determining the impacts of single and tandem gene deletions on growth and viability. Pathways that appear to be essential for N. gonorrhoeae based upon my modeling will be validated by testing small molecule inhibitor and/or isogenic mutant strains during in vitro growth and human cell line-based infection conditions. Special emphasis will be placed on pairs of genes that, when inhibited together, confer a lethal phenotype as these pairs represent ideal targets for drug development. Key essential targets will then be tested in a 'humanized' mouse model established to be susceptible to gonorrheal infection. This approach will identify targets for future efforts in drug development, while also developing a well characterized metabolic model of N. gonorrhoeae for further research efforts.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
449314
Name
Carruthers-Lay Duncan
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Metabolic modelling for drug development in Neisseria gonorrhoeae
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antimicrobial Resistance; Computational Biology; Drug Discovery; Metabolic Modelling; Neisseria Gonorrheae; Rna-Seq; Sexually-Transmitted Infection
Abstract
Neisseria gonorrhoeae is the bacteria that causes the sexually transmitted infection gonorrhea. Antimicrobial resistant (AMR) N. gonorrhoeae strains have become more common, leading to concerns about the rise of untreatable gonorrhea infections. There is, therefore, an urgent need for the development of new therapies to treat gonococcal infections. This project seeks to identify and characterize new targets for drug development by combing powerful computational models with state-of-the-art laboratory techniques. First, a computational model of N. gonorrhoeae metabolism will be developed using publicly available sequence data from over 7400 global gonococcal isolates. Representative strains will be grown in a variety of infection-mimicking culture conditions, and their growth characteristics will be used to validate and improve our computational model. The model will then be used to identify essential pathways through large scale simulations determining the impacts of single and tandem gene deletions on growth and viability. Pathways that appear to be essential for N. gonorrhoeae based upon my modeling will be validated by testing small molecule inhibitor and/or isogenic mutant strains during in vitro growth and human cell line-based infection conditions. Special emphasis will be placed on pairs of genes that, when inhibited together, confer a lethal phenotype as these pairs represent ideal targets for drug development. Key essential targets will then be tested in a 'humanized' mouse model established to be susceptible to gonorrheal infection. This approach will identify targets for future efforts in drug development, while also developing a well characterized metabolic model of N. gonorrhoeae for further research efforts.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Carruthers-Lay, Duncan
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~